• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质细胞衍生因子-1(SDF-1)通过诱导趋化作用、基质金属蛋白酶-9(MMP-9)活性和胶原迁移来募集破骨细胞前体。

Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration.

作者信息

Yu Xuefeng, Huang Yuefang, Collin-Osdoby Patricia, Osdoby Philip

机构信息

Department of Biology, Washington University, St Louis, Missouri 63130, USA.

出版信息

J Bone Miner Res. 2003 Aug;18(8):1404-18. doi: 10.1359/jbmr.2003.18.8.1404.

DOI:10.1359/jbmr.2003.18.8.1404
PMID:12929930
Abstract

UNLABELLED

Signals targeting OCs to bone and resorption sites are not well characterized. A chemoattractant receptor (CXCR4), highly expressed in murine OC precursors, mediated their chemokine (SDF-1)-induced chemoattraction, collagen transmigration, and MMP-9 expression. Thus, bone vascular and stromal SDF-1 may direct OC precursors into bone and marrow sites for development and bone resorption.

INTRODUCTION

Although chemokines are essential for trafficking and homing of circulating hematopoietic cells under normal and pathological conditions, their potential roles in osteoclast (OC) recruitment or function are generally unknown. CXCR4 and its unique ligand, stromal cell-derived factor-1 (SDF-1), critically control the matrix metalloproteinase (MMP)-dependent targeting of hematopoietic cells into bone and within the marrow microenvironment. Therefore, SDF-1/CXCR4 may regulate OC precursor recruitment to sites for development and activation.

METHODS

Chemokine receptor mRNA expression was analyzed during OC formation induced by RANKL in murine RAW 264.7 cells. SDF-1 versus RANKL effects on chemotaxis, transcollagen migration, MMP-9 expression and activity, OC development, and bone resorption were evaluated in RAW cells or RAW-OCs.

RESULTS

CXCR4 was highly expressed in RAW cells and downregulated during their RANKL development into bone-resorptive RAW-OCs. SDF-1, but not RANKL, elicited RAW cell chemotaxis. Conversely, RANKL, but not SDF-1, promoted RAW-OC development, TRAP activity, cathepsin K expression, and bone pit resorption, and SDF-1 did not modify these RANKL responses. Both SDF-1 and RANKL increased MMP-9, a matrix-degrading enzyme essential for OC precursor migration into developing bone marrow cavities, and increased transcollagen migration of RAW cells in a MMP-dependent manner. SDF-1 also upregulated MMP-9 in various primary murine OC precursor cells. Because RANKL induced a higher, more sustained expression of MMP-9 in RAW cells than did SDF-1, MMP-9 may have an additional role in mature OCs. Consistent with this, MMP-9 upregulation during RANKL-induced RAW-OC development was necessary for initiation of bone pit resorption.

CONCLUSIONS

SDF-1, a chemokine highly expressed by bone vascular endothelial and marrow stromal cells, may be a key signal for the selective attraction of circulating OC precursors into bone and their migration within marrow to appropriate perivascular stromal sites for RANKL differentiation into resorptive OCs. Thus, SDF-1 and RANKL likely serve complementary physiological functions, partly mediated through increases in MMP-9, to coordinate stages of OC precursor recruitment, development, and function.

摘要

未标记

靶向破骨细胞至骨骼和吸收部位的信号尚未得到充分表征。一种趋化因子受体(CXCR4)在小鼠破骨细胞前体中高度表达,介导其趋化因子(SDF-1)诱导的化学吸引、胶原迁移和MMP-9表达。因此,骨血管和基质中的SDF-1可能将破骨细胞前体引导至骨骼和骨髓部位进行发育和骨吸收。

引言

尽管趋化因子在正常和病理条件下对循环造血细胞的运输和归巢至关重要,但其在破骨细胞(OC)募集或功能中的潜在作用通常尚不清楚。CXCR4及其独特配体基质细胞衍生因子-1(SDF-1)严格控制造血细胞依赖基质金属蛋白酶(MMP)靶向进入骨骼和骨髓微环境。因此,SDF-1/CXCR4可能调节破骨细胞前体募集至发育和激活部位。

方法

在小鼠RAW 264.7细胞中,分析RANKL诱导破骨细胞形成过程中趋化因子受体mRNA表达。在RAW细胞或RAW破骨细胞中评估SDF-1与RANKL对趋化性、跨胶原迁移、MMP-9表达和活性、破骨细胞发育和骨吸收的影响。

结果

CXCR4在RAW细胞中高度表达,并在其RANKL诱导发育为骨吸收性RAW破骨细胞过程中下调。SDF-1而非RANKL引起RAW细胞趋化。相反,RANKL而非SDF-1促进RAW破骨细胞发育、TRAP活性、组织蛋白酶K表达和骨陷吸收,且SDF-1不改变这些RANKL反应。SDF-1和RANKL均增加MMP-9,MMP-9是破骨细胞前体迁移至发育中的骨髓腔所必需的基质降解酶,并以MMP依赖方式增加RAW细胞的跨胶原迁移。SDF-1还上调各种原代小鼠破骨细胞前体细胞中的MMP-9。由于RANKL在RAW细胞中诱导的MMP-9表达比SDF-1更高、更持久,MMP-9可能在成熟破骨细胞中具有额外作用。与此一致,RANKL诱导RAW破骨细胞发育过程中MMP-9上调是骨陷吸收起始所必需的。

结论

SDF-1是一种由骨血管内皮细胞和骨髓基质细胞高度表达的趋化因子,可能是将循环破骨细胞前体选择性吸引至骨骼并使其在骨髓内迁移至合适的血管周围基质部位以分化为吸收性破骨细胞的关键信号。因此,SDF-1和RANKL可能发挥互补的生理功能,部分通过增加MMP-9介导,以协调破骨细胞前体募集、发育和功能的各个阶段。

相似文献

1
Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration.基质细胞衍生因子-1(SDF-1)通过诱导趋化作用、基质金属蛋白酶-9(MMP-9)活性和胶原迁移来募集破骨细胞前体。
J Bone Miner Res. 2003 Aug;18(8):1404-18. doi: 10.1359/jbmr.2003.18.8.1404.
2
CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.CCR1趋化因子促进破骨细胞的趋化募集、RANKL发育及运动,并由成骨细胞中的炎性细胞因子诱导产生。
J Bone Miner Res. 2004 Dec;19(12):2065-77. doi: 10.1359/JBMR.040910. Epub 2004 Sep 20.
3
SDF-1 increases recruitment of osteoclast precursors by upregulation of matrix metalloproteinase-9 activity.基质细胞衍生因子-1通过上调基质金属蛋白酶-9的活性增加破骨细胞前体的募集。
Connect Tissue Res. 2003;44 Suppl 1:79-84.
4
Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.基质细胞衍生因子-1与其趋化因子受体CXCR4在前体细胞上的结合促进了人破骨细胞的趋化募集、发育和存活。
Bone. 2005 May;36(5):840-53. doi: 10.1016/j.bone.2005.01.021. Epub 2005 Mar 24.
5
Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.白细胞介素-1和肿瘤坏死因子-α激活人微血管内皮细胞,刺激循环中的人CD14+单核细胞黏附并经内皮迁移,这些单核细胞与核因子κB受体活化因子配体一起发育成功能性破骨细胞。
J Bone Miner Res. 2006 Feb;21(2):193-206. doi: 10.1359/JBMR.051027. Epub 2005 Nov 7.
6
Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.核因子κB受体激活剂配体诱导破骨细胞前体RAW264.7细胞中碳酸酐酶II、组织蛋白酶K和基质金属蛋白酶-9的表达。
Life Sci. 2007 Mar 13;80(14):1311-8. doi: 10.1016/j.lfs.2006.12.037. Epub 2007 Jan 23.
7
Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells.破骨细胞降解骨内膜成分并促进造血祖细胞的动员。
Nat Med. 2006 Jun;12(6):657-64. doi: 10.1038/nm1417. Epub 2006 May 21.
8
Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients.基质细胞衍生因子-1α血清水平升高与多发性骨髓瘤患者破骨细胞活性增加及溶骨性骨病相关。
Cancer Res. 2005 Mar 1;65(5):1700-9. doi: 10.1158/0008-5472.CAN-04-1687.
9
CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.趋化因子CXCL12上调人破骨细胞的骨吸收及基质金属蛋白酶-9的释放:类风湿性关节炎患者滑膜和骨组织中CXCL12水平升高。
J Cell Physiol. 2004 May;199(2):244-51. doi: 10.1002/jcp.10445.
10
Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.人小梁骨来源的成骨细胞在特定的无血清培养基中可在体外支持人破骨细胞的形成。
J Cell Physiol. 2005 Jun;203(3):573-82. doi: 10.1002/jcp.20255.

引用本文的文献

1
CXCR4 is a response gene for parathyroid hormone which affects osteoblast and osteoclast function in vitro.CXCR4是甲状旁腺激素的一个反应基因,其在体外影响成骨细胞和破骨细胞的功能。
Bone Joint Res. 2025 May 16;14(5):463-476. doi: 10.1302/2046-3758.145.BJR-2024-0167.R1.
2
Developmental Endothelial Locus-1 Promotes Osteoclast Differentiation and Activation.发育性内皮位点-1促进破骨细胞分化和激活。
Int J Mol Sci. 2025 Mar 16;26(6):2673. doi: 10.3390/ijms26062673.
3
Biomaterial Cues for Regulation of Osteoclast Differentiation and Function in Bone Regeneration.
用于调节骨再生中破骨细胞分化和功能的生物材料线索
Adv Ther (Weinh). 2025 Jan;8(1). doi: 10.1002/adtp.202400296. Epub 2024 Nov 15.
4
The story of clobenpropit and CXCR4: can be an effective drug in cancer and autoimmune diseases?氯苯丙哌及趋化因子受体4(CXCR4)的故事:能否成为治疗癌症和自身免疫性疾病的有效药物?
Front Pharmacol. 2024 Jul 12;15:1410104. doi: 10.3389/fphar.2024.1410104. eCollection 2024.
5
Pathological progression of osteoarthritis: a perspective on subchondral bone.骨关节炎的病理进展:对软骨下骨的认识。
Front Med. 2024 Apr;18(2):237-257. doi: 10.1007/s11684-024-1061-y. Epub 2024 Apr 15.
6
Single-cell RNA sequencing combined with proteomics of infected macrophages reveals prothymosin-α as a target for treatment of apical periodontitis.单细胞RNA测序结合感染巨噬细胞的蛋白质组学揭示了胸腺素α作为治疗根尖周炎的靶点。
J Adv Res. 2024 Dec;66:349-361. doi: 10.1016/j.jare.2024.01.018. Epub 2024 Jan 17.
7
The Role of TAM Receptors in Bone.TAM 受体在骨中的作用。
Int J Mol Sci. 2023 Dec 23;25(1):233. doi: 10.3390/ijms25010233.
8
Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases.间充质干细胞在自身免疫和自身炎症性疾病发病机制和治疗中的作用。
Int J Mol Sci. 2023 Nov 7;24(22):16040. doi: 10.3390/ijms242216040.
9
Osteoclasts at Bone Remodeling: Order from Order.骨重塑过程中的破骨细胞:有序源于有序。
Results Probl Cell Differ. 2024;71:227-256. doi: 10.1007/978-3-031-37936-9_12.
10
Tracking Targets of Dynamic Super-Enhancers to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells.追踪动态超级增强子的靶点,以更好地描述破骨细胞生成,并评估敌草隆对人骨细胞成熟的影响。
Environ Health Perspect. 2023 Jun;131(6):67007. doi: 10.1289/EHP11690. Epub 2023 Jun 12.